DC Funds, LP - Q2 2022 holdings

$7.25 Million is the total value of DC Funds, LP's 3 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
VACC  VACCITECH PLCads$2,858,000
-14.4%
642,2040.0%39.43%
-9.1%
HOWL  WEREWOLF THERAPEUTICS INC$2,409,000
-7.1%
589,1020.0%33.24%
-1.3%
 TSCAN THERAPEUTICS INC$1,981,000
+12.3%
630,0000.0%27.33%
+19.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VACCITECH PLC10Q3 202351.2%
WEREWOLF THERAPEUTICS INC10Q3 202348.8%
TSCAN THERAPEUTICS INC9Q3 202333.5%

View DC Funds, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-10
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View DC Funds, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (7249000.0 != 7248000.0)

Export DC Funds, LP's holdings